Top Markets
Coin of the day
Neovacs S.A. Neovacs S.A.

Neovacs S.A.

ALNEV
Hisse Senetlerindeki Sıralama #21228
Neovacs S.A., a biotechnology company, focuses on the development of... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Hisse Fiyatı
$0.00047446
Piyasa Değeri
$82.80
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-98.16%
Ülke
FR
Ticaret Neovacs S.A. (ALNEV)

Kategori

Neovacs S.A. (ALNEV) için hisse bölünme geçmişi
Neovacs S.A. hissesi (sembol: ALNEV) toplamda 6 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Jul 18, 2025 tarihinde gerçekleşmiştir.
Feb 01, 2022 tarihinden önce alınan bir ALNEV hissesi bugün 1.5625E-23 ALNEV hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
2025-07-18 1:1000 x0.001 x1.5625E-23
2024-12-05 1:10000 x0.0001 x1.5625E-20
2024-02-06 1:10000 x0.0001 x1.5625E-16
2023-06-05 1:8000 x0.000125 x1.5625E-12
2023-06-02 1:8000 x0.000125 x1.25E-8
2022-02-01 1:10000 x0.0001 x0.0001
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
5 x199
DK
1 x2
US
0 -
US
0 -
BE
0 -
NL